“It might start becoming the top circulating lineage,” Rajnaranayam said, predicting XEC will take the rest of October and ...

The EU's second-highest court, the General Court of the European Union, ruled partially against the Commission’s decision to ...

Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that ...

In fall and winter, COVID-19 transmission usually rises. LA County offers free boosters at county clinics and vaccination ...

Once thought of as a disease of age, new data about heart attacks is worrisome since it shows that it’s happening more often ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, both of whom expressed interest in supporting the activist investor's ...

Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...

The two companies brought legal action over a repeated sequence in the messenger RNA (mRNA) used in CureVac's patents in life ...

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...

The Centers for Disease Control and Prevention (CDC) currently recommends that everyone aged 6 months and up get the Moderna or Pfizer COVID-19 vaccines. The Novavax vaccine is authorized by the U.S.